StreetInsider.com News Articles

Avaí Bio and Austrianova agree on insulin cell supply for diabetes JV

Tue, 21 Jul 2026 08:03:14 -0400

Avaí Bio, Inc. (OTCQB: AVAI) and its joint venture partner Austrianova announced they have reached an agreement with an undisclosed partner to supply insulin-producing cells for Insulinova, their shared diabetes therapy program.

Insulinova is a joint venture established between Avaí Bio and Austrianova in late 2025. The therapy combines cells that have undergone a cell-programming process to become insulin-producing with Austrianova's Cell-in-a-Box® encapsulation technology. Once implanted, the encapsulated cells are designed to produce insulin in response to glucose levels, targeting people with type 1 and insulin-dependent type 2 diabetes.

The agreement remains subject to the execution of definitive agreements and customary closing

Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy

Tue, 21 Jul 2026 08:00:00 -0400

LAS VEGAS, July 21, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today announced that, together with its joint venture partner Austrianova, it has successfully concluded negotiations and reached agreement on the terms of a collaboration with a premier, internationally acclaimed, partner to provide insulin-producing cells for Insulinova's groundbreaking diabetes therapy.

Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy

Tue, 21 Jul 2026 08:00:00 -0400

Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy

Tue, 21 Jul 2026 08:00:00 -0400

Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy

Tue, 21 Jul 2026 08:00:00 -0400

Form 10-K AVAI BIO, INC. For: Mar 31

Tue, 14 Jul 2026 15:20:00 -0400

si-local-file:///var/storage/secattach/20260714/26767928.html

Form 10-K AVAI BIO, INC. For: Mar 31

Tue, 14 Jul 2026 15:20:00 -0400

si-local-file:///var/storage/secattach/20260714/26767928.html

Form NT 10-K AVAI BIO, INC. For: Mar 31

Tue, 30 Jun 2026 07:20:00 -0400

si-local-file:///var/storage/secattach/20260630/26709513.html

Form NT 10-K AVAI BIO, INC. For: Mar 31

Tue, 30 Jun 2026 07:20:00 -0400

si-local-file:///var/storage/secattach/20260630/26709513.html

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy